Vimarsana
Biggest News Aggregation in the World

Page 24 - Nuclear Export News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nuclear Export Today - Breaking & Trending Today

Karyopharm to Report Third Quarter 2022 Financial Results on November 3, 2022 - Vimarsana News

Karyopharm to Report Third Quarter 2022 Financial Results on November 3, 2022

Published: October 20, 2022

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it...

Source: prnewswire.com
Related Topics:
United KingdomSouth KoreaSelective Inhibitor Of Nuclear ExportPrnewswire Karyopharm Therapeutics IncKaryopharm Therapeutics IncCall ScheduledKaryopharm TherapeuticsSelective InhibitorNuclear ExportKaryopharm Therapeutics Inc
Karyopharm to Report Third Quarter 2022 Financial Results on November 3, 2022 - Vimarsana News

Karyopharm to Report Third Quarter 2022 Financial Results on November 3, 2022

Published: October 20, 2022

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it...

Source: prnewswire.com
Related Topics:
United KingdomSouth KoreaSelective Inhibitor Of Nuclear ExportPrnewswire Karyopharm Therapeutics IncKaryopharm Therapeutics IncCall ScheduledKaryopharm TherapeuticsSelective InhibitorNuclear Export
Karyopharm to Participate at Upcoming Investor Conferences - Vimarsana News

Karyopharm to Participate at Upcoming Investor Conferences

Published: September 7, 2022

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Source: prnewswire.com
Related Topics:
United KingdomSouth KoreaSelective Inhibitor Of Nuclear ExportPrnewswire Karyopharm Therapeutics IncKaryopharm Therapeutics IncMorgan StanleyAnnual Global Healthcare ConferenceHealthcare ConferenceSelective InhibitorNuclear ExportKaryopharm TherapeuticsKaryopharm Therapeutics Inc
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Published: September 1, 2022

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Source: prnewswire.com
Related Topics:
United KingdomSouth KoreaJohanna ShulmanSelective Inhibitor Of Nuclear ExportPrnewswire Karyopharm Therapeutics IncKaryopharm Therapeutics IncCompensation Committee Of Karyopharm Board DirectorsCompensation CommitteeVice PresidentProgram LeadStock Incentive PlanNasdaq Listing RuleSelective InhibitorNuclear ExportKaryopharm TherapeuticsKaryopharm Therapeutics Inc
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Published: September 1, 2022

NEWTON, Mass., Sept.1, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company...

Source: marketscreener.com
Related Topics:
United KingdomSouth KoreaJohanna ShulmanSelective Inhibitor Of Nuclear ExportPrnewswire Karyopharm Therapeutics IncKaryopharm Therapeutics IncCompensation Committee Of Karyopharm Board DirectorsCompensation CommitteeVice PresidentProgram LeadStock Incentive PlanNasdaq Listing RuleSelective InhibitorNuclear ExportKaryopharm Therapeutics